Published • loading... • Updated
Lupin gets FDA approval for Diazepam Injection, USP
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Lupin gets FDA approval for Diazepam Injection, USP
MUMBAI, India, and NAPLES, Fla.– Global pharmaceutical leader Lupin Limited today announced approval under the Federal Food, Drug, and Cosmetic Act (FD&C Act) of its Abbreviated New Drug Application for Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), Single-Dose Prefilled Syringes.The U.S. FDA has approved Lupin's Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), Single-Dose Prefilled Syringes, as bioequivalent to the reference listed drug (RLD) Valiu…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
